Loading viewer...
investor_presentation
Format: PDF investor_presentation
This presentation outlines Mesoblast's capital raising strategy, including an accelerated entitlement offer and institutional placement for new shares.
FDA Clears Ryoncil IND for Registration Trial in DMD
presentation
investor_presentation
69 Pages
Subsea 7
ISG Investor Presentation April 2022
investor_presentationinvestor_presentation
25 Pages
Information Services Group (ISG)
Pearl Global Industries 2023-24 Investor Presentation
investor_presentationinvestor_presentation
46 Pages
Pearl Global Industries Limited